J A Petrofski

Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.

M. Overman, W. Nelson, P. A. Campbell, 2000, International journal of oncology.